nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—HTR2A—conduct disorder	0.858	1	CbGaD
Cyproheptadine—SLC6A2—autonomic nervous system—conduct disorder	0.00511	0.362	CbGeAlD
Cyproheptadine—HTR2A—autonomic nervous system—conduct disorder	0.00307	0.218	CbGeAlD
Cyproheptadine—Protriptyline—SLC6A4—conduct disorder	0.00156	0.187	CrCbGaD
Cyproheptadine—HTR6—brain—conduct disorder	0.00102	0.0726	CbGeAlD
Cyproheptadine—Cyclobenzaprine—HTR2A—conduct disorder	0.000896	0.107	CrCbGaD
Cyproheptadine—Loxapine—DRD4—conduct disorder	0.000887	0.106	CrCbGaD
Cyproheptadine—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.000866	0.00726	CbGpPWpGaD
Cyproheptadine—HRH1—Monoamine GPCRs—HTR2A—conduct disorder	0.00085	0.00713	CbGpPWpGaD
Cyproheptadine—CHRM1—Monoamine GPCRs—HTR2A—conduct disorder	0.000847	0.00711	CbGpPWpGaD
Cyproheptadine—CHRM3—Monoamine GPCRs—HTR2A—conduct disorder	0.000845	0.00709	CbGpPWpGaD
Cyproheptadine—UGT1A3—NRF2 pathway—SLC6A4—conduct disorder	0.000839	0.00704	CbGpPWpGaD
Cyproheptadine—CHRM2—Monoamine GPCRs—HTR2A—conduct disorder	0.000837	0.00702	CbGpPWpGaD
Cyproheptadine—HTR1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000829	0.00695	CbGpPWpGaD
Cyproheptadine—HTR2C—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000825	0.00692	CbGpPWpGaD
Cyproheptadine—Clozapine—DRD4—conduct disorder	0.000745	0.0891	CrCbGaD
Cyproheptadine—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000728	0.00611	CbGpPWpGaD
Cyproheptadine—HRH1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000715	0.00599	CbGpPWpGaD
Cyproheptadine—CHRM1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000712	0.00598	CbGpPWpGaD
Cyproheptadine—CHRM3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00071	0.00596	CbGpPWpGaD
Cyproheptadine—CHRM2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000703	0.0059	CbGpPWpGaD
Cyproheptadine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000687	0.00576	CbGpPWpGaD
Cyproheptadine—Mianserin—SLC6A4—conduct disorder	0.00067	0.0802	CrCbGaD
Cyproheptadine—CHRM2—brain—conduct disorder	0.000614	0.0435	CbGeAlD
Cyproheptadine—SLC6A2—NRF2 pathway—SLC6A4—conduct disorder	0.000604	0.00507	CbGpPWpGaD
Cyproheptadine—HTR6—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000603	0.00506	CbGpPWpGaD
Cyproheptadine—Nortriptyline—SLC6A4—conduct disorder	0.000599	0.0717	CrCbGaD
Cyproheptadine—HTR2C—brain—conduct disorder	0.000592	0.0419	CbGeAlD
Cyproheptadine—HTR2A—GPCRs, Other—DRD4—conduct disorder	0.00058	0.00487	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCRs, Other—DRD4—conduct disorder	0.000575	0.00482	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCRs, Other—DRD4—conduct disorder	0.00057	0.00478	CbGpPWpGaD
Cyproheptadine—CHRM1—brain—conduct disorder	0.000559	0.0396	CbGeAlD
Cyproheptadine—UGT1A3—Biological oxidations—COMT—conduct disorder	0.000558	0.00468	CbGpPWpGaD
Cyproheptadine—CHRM1—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.000557	0.00467	CbGpPWpGaD
Cyproheptadine—HTR2B—brain—conduct disorder	0.000556	0.0394	CbGeAlD
Cyproheptadine—CHRM3—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.000555	0.00465	CbGpPWpGaD
Cyproheptadine—UGT1A3—Biological oxidations—MAOA—conduct disorder	0.000554	0.00464	CbGpPWpGaD
Cyproheptadine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00055	0.00462	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metapathway biotransformation—COMT—conduct disorder	0.00055	0.00461	CbGpPWpGaD
Cyproheptadine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.000549	0.00461	CbGpPWpGaD
Cyproheptadine—Loxapine—SLC6A4—conduct disorder	0.000532	0.0637	CrCbGaD
Cyproheptadine—Mianserin—HTR2A—conduct disorder	0.000515	0.0616	CrCbGaD
Cyproheptadine—CHRM3—brain—conduct disorder	0.0005	0.0354	CbGeAlD
Cyproheptadine—HTR1A—brain—conduct disorder	0.000498	0.0353	CbGeAlD
Cyproheptadine—SLC6A2—brain—conduct disorder	0.000494	0.035	CbGeAlD
Cyproheptadine—HTR1A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000464	0.00389	CbGpPWpGaD
Cyproheptadine—Nortriptyline—HTR2A—conduct disorder	0.00046	0.0551	CrCbGaD
Cyproheptadine—HTR6—GPCR ligand binding—CGA—conduct disorder	0.000459	0.00385	CbGpPWpGaD
Cyproheptadine—DRD2—brain—conduct disorder	0.00045	0.0319	CbGeAlD
Cyproheptadine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000446	0.00374	CbGpPWpGaD
Cyproheptadine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000444	0.00372	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR ligand binding—CGA—conduct disorder	0.000419	0.00352	CbGpPWpGaD
Cyproheptadine—Amitriptyline—SLC6A4—conduct disorder	0.000415	0.0497	CrCbGaD
Cyproheptadine—Loxapine—HTR2A—conduct disorder	0.000409	0.049	CrCbGaD
Cyproheptadine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000401	0.00336	CbGpPWpGaD
Cyproheptadine—HTR6—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000394	0.00331	CbGpPWpGaD
Cyproheptadine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000394	0.0033	CbGpPWpGaD
Cyproheptadine—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000392	0.00329	CbGpPWpGaD
Cyproheptadine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000386	0.00323	CbGpPWpGaD
Cyproheptadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000385	0.00323	CbGpPWpGaD
Cyproheptadine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000383	0.00322	CbGpPWpGaD
Cyproheptadine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000382	0.00321	CbGpPWpGaD
Cyproheptadine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000379	0.00318	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCRs, Other—HTR2A—conduct disorder	0.000375	0.00315	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.000372	0.00312	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00036	0.00302	CbGpPWpGaD
Cyproheptadine—HRH1—brain—conduct disorder	0.000356	0.0252	CbGeAlD
Cyproheptadine—HTR1A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000349	0.00293	CbGpPWpGaD
Cyproheptadine—Clozapine—HTR2A—conduct disorder	0.000343	0.0411	CrCbGaD
Cyproheptadine—HTR1A—GPCR ligand binding—CGA—conduct disorder	0.00034	0.00285	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR ligand binding—CGA—conduct disorder	0.000338	0.00284	CbGpPWpGaD
Cyproheptadine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000338	0.00283	CbGpPWpGaD
Cyproheptadine—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000333	0.00279	CbGpPWpGaD
Cyproheptadine—CHRM1—Circadian rythm related genes—SLC6A4—conduct disorder	0.000326	0.00273	CbGpPWpGaD
Cyproheptadine—Amitriptyline—HTR2A—conduct disorder	0.000319	0.0382	CrCbGaD
Cyproheptadine—HTR1A—G alpha (i) signalling events—DRD4—conduct disorder	0.000314	0.00264	CbGpPWpGaD
Cyproheptadine—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.000313	0.00262	CbGpPWpGaD
Cyproheptadine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000308	0.00259	CbGpPWpGaD
Cyproheptadine—CHRM1—Circadian rythm related genes—DRD4—conduct disorder	0.000306	0.00257	CbGpPWpGaD
Cyproheptadine—SLC6A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000305	0.00255	CbGpPWpGaD
Cyproheptadine—HRH1—IL-4 Signaling Pathway—EP300—conduct disorder	0.000304	0.00255	CbGpPWpGaD
Cyproheptadine—HTR2B—G alpha (q) signalling events—HTR2A—conduct disorder	0.000304	0.00255	CbGpPWpGaD
Cyproheptadine—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000302	0.00253	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000298	0.0025	CbGpPWpGaD
Cyproheptadine—HTR2A—brain—conduct disorder	0.000297	0.021	CbGeAlD
Cyproheptadine—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000296	0.00248	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.000294	0.00246	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR ligand binding—CGA—conduct disorder	0.000293	0.00246	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR ligand binding—CGA—conduct disorder	0.000292	0.00245	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000292	0.00245	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR ligand binding—CGA—conduct disorder	0.000291	0.00244	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00029	0.00243	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.000288	0.00242	CbGpPWpGaD
Cyproheptadine—HTR1A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000285	0.00239	CbGpPWpGaD
Cyproheptadine—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000276	0.00232	CbGpPWpGaD
Cyproheptadine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000272	0.00228	CbGpPWpGaD
Cyproheptadine—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.000267	0.00224	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—CGA—conduct disorder	0.000259	0.00218	CbGpPWpGaD
Cyproheptadine—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000257	0.00216	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR ligand binding—DRD4—conduct disorder	0.000257	0.00216	CbGpPWpGaD
Cyproheptadine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000256	0.00215	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000252	0.00211	CbGpPWpGaD
Cyproheptadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000251	0.00211	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000251	0.0021	CbGpPWpGaD
Cyproheptadine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00025	0.0021	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00025	0.0021	CbGpPWpGaD
Cyproheptadine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000249	0.00209	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000247	0.00208	CbGpPWpGaD
Cyproheptadine—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.000245	0.00205	CbGpPWpGaD
Cyproheptadine—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000241	0.00203	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—CGA—conduct disorder	0.000237	0.00199	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—CGA—conduct disorder	0.000236	0.00198	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000235	0.00197	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR ligand binding—DRD4—conduct disorder	0.000235	0.00197	CbGpPWpGaD
Cyproheptadine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00022	0.00185	CbGpPWpGaD
Cyproheptadine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000219	0.00184	CbGpPWpGaD
Cyproheptadine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000219	0.00184	CbGpPWpGaD
Cyproheptadine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000216	0.00181	CbGpPWpGaD
Cyproheptadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000215	0.00181	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—CGA—conduct disorder	0.000215	0.0018	CbGpPWpGaD
Cyproheptadine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000215	0.0018	CbGpPWpGaD
Cyproheptadine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000214	0.0018	CbGpPWpGaD
Cyproheptadine—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000212	0.00178	CbGpPWpGaD
Cyproheptadine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000212	0.00178	CbGpPWpGaD
Cyproheptadine—CHRM1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000212	0.00177	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—CGA—conduct disorder	0.000211	0.00177	CbGpPWpGaD
Cyproheptadine—CHRM3—G alpha (q) signalling events—HTR2A—conduct disorder	0.000211	0.00177	CbGpPWpGaD
Cyproheptadine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000201	0.00169	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000192	0.00161	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000191	0.0016	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00019	0.0016	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.00019	0.0016	CbGpPWpGaD
Cyproheptadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00019	0.00159	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000189	0.00159	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000189	0.00159	CbGpPWpGaD
Cyproheptadine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000189	0.00159	CbGpPWpGaD
Cyproheptadine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000189	0.00158	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.000174	0.00146	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.000174	0.00146	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000169	0.00141	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR ligand binding—HTR2A—conduct disorder	0.000168	0.00141	CbGpPWpGaD
Cyproheptadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000167	0.0014	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000167	0.0014	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000166	0.00139	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.000166	0.00139	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—CGA—conduct disorder	0.000165	0.00138	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—CGA—conduct disorder	0.000165	0.00138	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000164	0.00138	CbGpPWpGaD
Cyproheptadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000164	0.00138	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.000164	0.00138	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000164	0.00137	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR ligand binding—DRD4—conduct disorder	0.000164	0.00137	CbGpPWpGaD
Cyproheptadine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000163	0.00137	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000163	0.00137	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR ligand binding—DRD4—conduct disorder	0.000163	0.00137	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.000163	0.00137	CbGpPWpGaD
Cyproheptadine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000162	0.00136	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000161	0.00135	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.000161	0.00135	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000153	0.00128	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	0.000153	0.00128	CbGpPWpGaD
Cyproheptadine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000151	0.00126	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.000151	0.00126	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—CGA—conduct disorder	0.00015	0.00126	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—CGA—conduct disorder	0.00015	0.00126	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—CGA—conduct disorder	0.000149	0.00125	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.000148	0.00124	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—DRD4—conduct disorder	0.000145	0.00122	CbGpPWpGaD
Cyproheptadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000143	0.0012	CbGpPWpGaD
Cyproheptadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000141	0.00118	CbGpPWpGaD
Cyproheptadine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00014	0.00118	CbGpPWpGaD
Cyproheptadine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00014	0.00117	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CGA—conduct disorder	0.000139	0.00117	CbGpPWpGaD
Cyproheptadine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000138	0.00116	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	0.000133	0.00111	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—DRD4—conduct disorder	0.000132	0.00111	CbGpPWpGaD
Cyproheptadine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00013	0.00109	CbGpPWpGaD
Cyproheptadine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000128	0.00107	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CGA—conduct disorder	0.000127	0.00107	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	0.000124	0.00104	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	0.000124	0.00104	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—DRD4—conduct disorder	0.00012	0.00101	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—WASF1—conduct disorder	0.000112	0.000936	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.000109	0.000915	CbGpPWpGaD
Cyproheptadine—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.000108	0.000907	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	0.000108	0.000902	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	0.000107	0.000898	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	0.000107	0.000898	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	0.000107	0.000895	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	0.000106	0.000892	CbGpPWpGaD
Cyproheptadine—CHRM1—Circadian rythm related genes—EP300—conduct disorder	0.000106	0.000887	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—CGA—conduct disorder	0.000106	0.000885	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	0.000105	0.000884	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CGA—conduct disorder	0.000103	0.000864	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CGA—conduct disorder	0.000103	0.00086	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—WASF1—conduct disorder	0.000102	0.000854	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	9.77e-05	0.000819	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	9.72e-05	0.000815	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—COMT—conduct disorder	9.54e-05	0.0008	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	9.48e-05	0.000795	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—MAOA—conduct disorder	9.47e-05	0.000794	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	9.44e-05	0.000792	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	9.29e-05	0.000779	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	9.27e-05	0.000778	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	9.24e-05	0.000775	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	9.21e-05	0.000773	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	9.12e-05	0.000765	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CGA—conduct disorder	9.05e-05	0.000759	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CGA—conduct disorder	8.9e-05	0.000747	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CGA—conduct disorder	8.88e-05	0.000745	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CGA—conduct disorder	8.85e-05	0.000743	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CGA—conduct disorder	8.83e-05	0.00074	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CGA—conduct disorder	8.74e-05	0.000733	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	8.65e-05	0.000726	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—HTR2A—conduct disorder	8.61e-05	0.000722	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—DRD4—conduct disorder	8.58e-05	0.000719	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	8.44e-05	0.000708	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—DRD4—conduct disorder	8.42e-05	0.000706	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—DRD4—conduct disorder	8.39e-05	0.000704	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—DRD4—conduct disorder	8.37e-05	0.000702	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	8.28e-05	0.000695	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—WASF1—conduct disorder	8.26e-05	0.000693	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—WASF1—conduct disorder	8.21e-05	0.000689	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	7.86e-05	0.000659	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—DRD4—conduct disorder	7.79e-05	0.000654	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—WASF1—conduct disorder	7.25e-05	0.000608	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—WASF1—conduct disorder	7.13e-05	0.000598	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—WASF1—conduct disorder	7.12e-05	0.000597	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—DRD4—conduct disorder	7.12e-05	0.000597	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—WASF1—conduct disorder	7.1e-05	0.000595	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—WASF1—conduct disorder	7.07e-05	0.000593	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	7.02e-05	0.000589	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—WASF1—conduct disorder	7e-05	0.000588	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	6.98e-05	0.000586	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	6.37e-05	0.000535	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	6.34e-05	0.000532	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	6.16e-05	0.000517	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	6.05e-05	0.000507	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	6.03e-05	0.000506	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	6.01e-05	0.000504	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	5.95e-05	0.000499	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—DRD4—conduct disorder	5.77e-05	0.000484	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—DRD4—conduct disorder	5.74e-05	0.000481	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	5.6e-05	0.000469	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	5.49e-05	0.000461	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	5.48e-05	0.000459	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	5.46e-05	0.000458	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	5.41e-05	0.000453	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—HTR2A—conduct disorder	5.09e-05	0.000427	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—DRD4—conduct disorder	5.07e-05	0.000425	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—DRD4—conduct disorder	4.98e-05	0.000418	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—DRD4—conduct disorder	4.97e-05	0.000417	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—DRD4—conduct disorder	4.96e-05	0.000416	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—DRD4—conduct disorder	4.94e-05	0.000415	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—DRD4—conduct disorder	4.89e-05	0.000411	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—COMT—conduct disorder	4.76e-05	0.0004	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—MAOA—conduct disorder	4.73e-05	0.000397	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—HTR2A—conduct disorder	4.64e-05	0.000389	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—EP300—conduct disorder	4.09e-05	0.000343	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	3.76e-05	0.000316	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	3.75e-05	0.000314	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HTR2A—conduct disorder	3.31e-05	0.000277	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HTR2A—conduct disorder	3.25e-05	0.000272	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HTR2A—conduct disorder	3.23e-05	0.000271	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HTR2A—conduct disorder	3.22e-05	0.00027	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	3.19e-05	0.000268	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—EP300—conduct disorder	2.69e-05	0.000226	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—EP300—conduct disorder	2.46e-05	0.000206	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—EP300—conduct disorder	2.04e-05	0.000171	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EP300—conduct disorder	1.99e-05	0.000167	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EP300—conduct disorder	1.98e-05	0.000166	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EP300—conduct disorder	1.75e-05	0.000147	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EP300—conduct disorder	1.72e-05	0.000145	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EP300—conduct disorder	1.72e-05	0.000144	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EP300—conduct disorder	1.71e-05	0.000144	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EP300—conduct disorder	1.71e-05	0.000143	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EP300—conduct disorder	1.69e-05	0.000142	CbGpPWpGaD
